Literature DB >> 17412555

Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells.

Melinda von Borstel Smith1, Kristi Crofoot, Rosita Rodriguez-Proteau, Theresa M Filtz.   

Abstract

Adverse effects of anti-seizure/anti-epileptic medications on bone density have been observed and reported since the early 1960s. Phenytoin and carbamazepine are two commonly prescribed anti-epileptic drugs most frequently associated with osteomalacia including fractures, bone demineralization, and reduced bone formation. The mechanism by which anti-epileptic drugs induce bone loss is not fully explained. We hypothesized that anti-epileptic drugs may impair dietary calcium absorption in the intestine. Using Caco-2 cells, a model transport system for study of the function of the intestinal epithelium, we determined the effects of several anti-epileptic drugs on intestinal epithelial calcium transport. In our system, phenytoin and carbamazepine dose-dependently inhibit active calcium transport from the apical to basolateral side of Caco-2 cells under physiologic calcium conditions. Vitamin D ameliorates the anti-epileptic drug-induced decrease in calcium permeability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412555     DOI: 10.1016/j.tiv.2007.02.008

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users.

Authors:  Kathryn E Childs; Sarah L Fishman; Catherine Constable; Julio A Gutierrez; Christina M Wyatt; Douglas T Dieterich; Michael P Mullen; Andrea D Branch
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

2.  Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.

Authors:  Peter L Havens; Charles B Stephensen; Rohan Hazra; Patricia M Flynn; Craig M Wilson; Brandy Rutledge; James Bethel; Cynthia G Pan; Leslie R Woodhouse; Marta D Van Loan; Nancy Liu; Jorge Lujan-Zilbermann; Alyne Baker; Bill G Kapogiannis; Kathleen Mulligan
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

Review 3.  A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.

Authors:  Richard H Lee; Kenneth W Lyles; Cathleen Colón-Emeric
Journal:  Am J Geriatr Pharmacother       Date:  2010-02

4.  Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.

Authors:  A M Pack; M J Morrell; A Randall; D J McMahon; E Shane
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

Review 5.  Interplay between vitamin D and the drug metabolizing enzyme CYP3A4.

Authors:  Zhican Wang; Erin G Schuetz; Yang Xu; Kenneth E Thummel
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-15       Impact factor: 4.292

6.  A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.

Authors:  Jane P F Bai; Theodore Sakellaropoulos; Leonidas G Alexopoulos
Journal:  Toxins (Basel)       Date:  2017-03-10       Impact factor: 4.546

7.  Bone health in pediatric patients with neurological disorders.

Authors:  Ara Ko; Juhyun Kong; Furkat Samadov; Akmal Mukhamedov; Young Mi Kim; Yun-Jin Lee; Sang Ook Nam
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.